Back to company

Alpine-Bio ApS: Financial statements 2024

CVR: 44607379

Alpine-Bio ApS (CVR 44607379) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 94,889 and a net result of DKK -156,738. Equity amounted to DKK 383,262. The solvency ratio was 19.3%. The company had 1 employee in the financial year.

Gross Profit
94,889 kr.
Profit/Loss
-156,738 kr.
Equity
383,262 kr.
Total Assets
1,989,661 kr.
Employees
1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Alpine-Bio ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Søren Anker Nielsen joins Alpine-Bio ApS as directorFeb 1, 2024

As of February 1, 2024, Søren Anker Nielsen is registered as director of Alpine-Bio ApS.

Alpine-Bio ApS is foundedFeb 1, 2024

Alpine-Bio ApS was founded on February 1, 2024.

About Alpine-Bio ApS

Alpine-Bio ApS is a Danish company of the type Anpartsselskab based in Albertslund, founded in 2024. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Søren Anker Nielsen. The company is owned by JUUZ ApS and S21 Holding ApS. In 2025, the company reported a gross profit of DKK 179,268 and a net result of DKK -61,697 compared with DKK -156,738 the year before. Equity amounted to DKK 621,565.

Other financial years